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The integrin a6b4 plays a crucial role in the assem-
bly and maintenance of hemidesmosomes. Previous
work has shown that the recruitment of plectin into
hemidesmosomes is dependent on b4 and involves a
region of the b4 cytoplasmic domain, which contains
the ®rst two ®bronectin (FNIII) repeats and a short
region of the connecting segment. Two missense
mutations (R1225H and R1281W) in b4 that are
responsible for nonlethal forms of epidermolysis bul-
losa are located in the second FNIII repeat. One of
them is con®ned to a loop region that connects two
b strands (EC¢) whereas the other is located at the N-
terminal end of the second FNIII repeat. We here
report that these mutations render b4 unable to
interact with plectin and prevent the localization of
plectin in hemidesmosomes. Substitution of a lysine
residue (K1279W) that forms part of the same loop
as R1281 had no effect on the ability of b4 to recruit
plectin. Furthermore, we show that an extended
loop structure in b4, composed of the amino acids
DDN (1262±1264), which resembles the RGD integ-
rin-binding loop in ®bronectin, is not involved in the
binding to plectin. These results further demonstrate
that binding of b4 to plectin is essential for the
proper formation and function of hemidesmosomes
and that loss of the interaction between b4 and plec-
tin is associated with a mild form of epidermolysis
bullosa. Key words: cytoskeleton/epidermolysis bullosa/
hemidesmosome/integrin/plectin. J Invest Dermatol
117:1405±1411, 2001
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emidesmosomes are stable adhesion complexes that
facilitate the linkage between the keratin inter-
mediate ®lament system and the extracellular
matrix in strati®ed and pseudo-strati®ed epithelia
(Borradori and Sonnenberg, 1999). They consist of
at least ®ve components of which three are transmembrane
spanning proteins: the integrin a6b4, which serves as a receptor
for laminin-5 (Stepp et al, 1990; Sonnenberg et al, 1991; Niessen et
al, 1994), the collagenous bullous pemphigoid antigen BP180
(Giudice et al, 1992), and the tetraspanin CD151 (Sterk et al, 2000).
The two cytoplasmic constituents of hemidesmosomes include the
plakin family members plectin (Hieda et al, 1992; Gache et al, 1996)
and the bullous pemphigoid antigen BP230 (Stanley et al, 1981).
Abnormalities in hemidesmosomal components or structures have
been associated with tissue fragility and blistering disorders of the
skin, demonstrating the importance of hemidesmosomes for the
adhesion between the dermis and the epidermis, as well as for tissue
integrity (Stanley, 1995; Christiano and Uitto, 1996). For example,
patients who lack a6 or b4, due to mutations in the genes encoding
these subunits, have rudimentary hemidesmosomes or completely
lack these structures (Vidal et al, 1995; Niessen et al, 1996;
Pulkkinen et al, 1997; Ruzzi et al, 1997). These patients are
characterized by pyloric atresia associated with junctional epider-
molysis bullosa (PA-JEB). They suffer from severe blistering of the
skin and often do not survive beyond the age of 1 y. Similarly, a6
and b4 null mice exhibit severe skin blistering and die perinatally
(Dowling et al, 1996; Georges-Labouesse et al, 1996; van der Neut
et al, 1996). Most of the mutations identi®ed in PA-JEB patients
concern nonsense mutations or mutations at splice sites that result
in the early termination of translation of the b4 protein. Missense
mutations resulting in the substitution of a single amino acid have
also been demonstrated. Two of these point mutations (R1225H
and R1281W) have been disclosed in patients with a nonlethal
form of epidermolysis bullosa (EB) (Pulkkinen et al, 1998; Nakano
et al, 2001). Mutations in the plectin gene are responsible for a
variant form of EB with a late onset of muscular dystrophy. They
have been associated with a reduced anchorage of intermediate
®laments to hemidesmosomes (McLean et al, 1996; Smith et al,
1996). As a result, keratinocytes are more fragile and rupture easily
upon application of stress, resulting in a split through the basal
keratinocytes. Mice that are de®cient in plectin recapitulate most of
the features of these patients, but die much earlier around birth
probably because essential functions of plectin are lost in other
tissues, e.g., the heart and skeletal muscle (AndraÈ et al, 1997).
The integrin b4 subunit is characterized by an unusually long
cytoplasmic domain that harbors four ®bronectin type III (FNIII)
repeats, residing in two pairs separated by a connecting segment
(Hogervorst et al, 1990; Suzuki and Naitoh, 1990). Previous studies
have shown that a fragment of b4 containing the ®rst pair of FNIII
repeats and the ®rst 36 amino acids (1320±1355) of the connecting
segment are crucial for the recruitment of plectin in hemidesmo-
somes (Niessen et al, 1997a; Nievers et al, 1998). Furthermore, it
was shown that this fragment contains a binding site for plectin and
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that this interaction depends on the presence of the actin binding
domain (ABD) of plectin (Geerts et al, 1999). The mutations that
have been described in patients with nonlethal forms of EB
localized at the same region that we identi®ed to be essential for the
recruitment of plectin in hemidesmosomes. They therefore may
affect the binding of b4 to plectin. The determination of the crystal
structure of the ®rst pair of FNIII repeats (de Pereda et al, 1999)
allowed us to map the location of these mutations on the three-
dimensional structure. It thus became clear that the mutations are
present in close proximity to each other and that they are located
on the same side of the structure. Interestingly, both mutations
concern an arginine residue, which is considered to be strongly
basic. The mutations are separated from the extended C±C¢ loop in
the second FNIII repeat consisting of the residues DDN (1262±
1264) that, in analogy to an RGD loop region in ®bronectin, has
been suggested to function as a potential protein binding site.
Previous studies have indicated that the R1281W mutation
abolishes the binding of b4 to plectin (Geerts et al, 1999; Nievers
et al, 2000). In this study, we con®rm this ®nding and show that the
mutation R1225H has the same effect. The mutation K1279W that
is part of the loop structure as is R1281W did not abrogate binding.
Finally, we show that the DDN loop plays no role in the binding of
b4 to the ABD of plectin and thus may constitute a binding site for
an as yet unidenti®ed protein.
MATERIALS AND METHODS
Cell lines and antisera African green monkey kidney cells (COS-7)
were maintained in Dulbecco's modi®ed Eagle's medium (DMEM;
Gibco-BRL) supplemented with 10% fetal bovine serum (Gibco-BRL),
100 U per ml penicillin, and 100 mg per ml streptomycin, in a
humidi®ed 5% CO2 atmosphere at 37°C. The b4-de®cient PA-JEB
keratinocyte cell line has been described previously (Schaapveld et al,
1998). PA-JEB cells were cultured in keratinocyte serum-free medium
(SFM; Gibco-BRL) supplemented with 50 mg per ml bovine pituitary
extract, 5 ng per ml epidermal growth factor, 100 U per ml penicillin,
and 100 mg per ml streptomycin. The mouse monoclonal antibody
(MoAb) 121 (Hieda et al, 1992; Okumura et al, 1999) against HD1/
plectin was a kind gift of Dr. K. Owaribe (University of Nagoya, Japan)
Figure 1. Crystal structure of the ®rst pair of
FNIII repeats of b4. (A) Ribbon diagram
showing the amino acids R1225, K1279, and
R1281 and the residues D1262, D1263, and
N1264 of the DDN loop. (B) Same as (A) with
the indicated residues as surface ®lls. (C) Space-
®lling model according to surface charge
distribution with red representing residues with
acidic side chains, white representing neutral side
chains, and blue basic side chains. (D) Same as
(C), with the residues R1225, K1279, and R1281
being highlighted in blue, red, and yellow and the
residues DDN (1262±1264) in orange. Images
prepared with WebLab using the coordinates from
1qg3.
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and the rat MoAb 439-9B (Kennel et al, 1989) against b4 was obtained
from Dr. S.J. Kennel (Oak Ridge Laboratory, Oak Ridge, TN).
Secondary antibodies were purchased from Rockland (Gilbertsville, PA)
[¯uorescein isothiocyanate (FITC) conjugated goat antimouse IgG] and
Molecular Probes (Eugene, OR) (Texas-Red-conjugated goat antirat
IgG).
Construction of expression plasmid of b4 mutants The
construction of the pRc/CMV-b4 expression vector has been described
previously (Niessen et al, 1997a). The polymerase chain reaction (PCR)
overlap extension method was used to introduce mutations (R1225H,
K1279W, R1281W, and D1263E) and a three amino acid deletion
(DDDN, positions 1262±1264) in the b4 cytoplasmic domain. Sense and
corresponding antisense oligonucleotides containing the appropriate
mutations or deletion were used together with 5¢ (CGTAGAAC-
GTCATCGCTG) and 3¢ (CCTGCTGAAGCCTGACACTC) primers.
The resulting PCR fragments of 1.5 kb were digested with BglII and
BssHII and used to replace the corresponding fragment of the wild-type
b4 cDNA in the plasmid pUC-b4 (Niessen et al, 1997a). Subsequently,
the full-length b4 cDNAs carrying the various mutations were released
by EcoRI digestion and ligated into the eukaryotic expression vector
pRc/CMV (InVitrogen, San Diego, CA). The correctness of all
constructs was veri®ed by sequencing.
DNA transfections PA-JEB cells were grown to 40% con¯uency in
12-well tissue culture plates (Falcon; Becton Dickinson, Lincoln Park,
NJ). Transient transfections were performed with 0.8 mg cDNA using
lipofectin (Gibco-BRL) according to the manufacturer's instructions.
Transfection mixtures were replaced by SFM after 6 h and incubated in
this medium overnight. Subsequently, the SFM was replaced with
HAMF12/DMEM (1:3) for an additional 24 h after which the cells were
assayed for gene expression. COS-7 cells were transiently transfected
using the DEAE-dextran method (Cullen, 1987) with 2 mg of cDNA per
construct and assayed for gene expression after 48 h.
Immunoblot analysis Lysates were prepared from transfected COS-7
cells by suspending the cells in sodium dodecyl sulfate (SDS) sample
buffer and boiling for 5 min. Proteins were separated by SDS
polyacrylamide gel electrophoresis (PAGE), transferred onto PVDF
membranes (Immobilon-P; Millipore), blocked for 1 h with 2% baby
milk powder in TBST (10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.01%
Tween-20) and probed with the rat MoAb 439-9B. The membrane was
washed with TBST and then incubated with horseradish peroxidase
conjugated sheep antimouse antibody (Amersham Pharmacia Biotech,
Uppsala, Sweden) for 1 h at room temperature. After washing, the
membrane was subjected to enhanced chemiluminescence (Amersham
Pharmacia Biotech) and exposed to ®lm.
Immuno¯uorescence microscopy PA-JEB cells grown on glass
coverslips were ®xed with 1% paraformaldehyde in phosphate-buffered
saline (PBS) for 10 min and permeabilized with 0.5% Triton X-100 in
PBS for 5 min at room temperature. After rinsing in PBS and blocking
with 2% bovine serum albumin in PBS for 60 min at room temperature,
the cells were incubated with primary antibodies for 45 min at room
temperature and then washed three times with PBS. Cells were
subsequently incubated with FITC-labeled antimouse IgG and Texas-
Red-labeled antirat IgG for 45 min at room temperature. Coverslips
were washed three times, mounted in Mowiol/DAPCO overnight, and
viewed under a Leica confocal scanning laser microscope.
Yeast two-hybrid assay The GAL4 fusion plasmids used in this study
are depicted in Fig 4. Superscript numbers correspond to the b4 amino
acid residues (according to Niessen et al, 1997a) that were fused in-frame
to the GAL4 activation domain (AD). The b4 fragments (1115±1457)
containing different mutations were generated by PCR ampli®cation of
the corresponding full-length mutant b4A cDNAs using sense and
antisense primers encoding BamHI restriction sites at their 5¢ ends. The
ampli®ed fragments were gel-puri®ed, digested with BamHI, and cloned
in the corresponding site of the yeast GAL4(AD) expression vector
pACT2 (Clontech Laboratory). The construction of the plectin ABD,
fused in-frame to the GAL4 DNA-binding domain (BD) of the pAS2.1
vector, has been described previously (Geerts et al, 1999).
The PJ69-4 A strain (a kind gift of Dr. P. James, University of
Winsconsin, Madison, WI), containing the genetic markers trp1-901,
leu2-3, his3-200, gal4D, gal80D, LYS2::GAL1-HIS3, and GAL2-ADE2
(James et al, 1996), was used as host for all two-hybrid assays presented
in this study. This strain contains two tightly regulated selectable GAL4
driven reporter genes, His and Ade, allowing sensitive detection of
protein±protein interactions containing GAL4 fusion proteins. The
GAL4(AD) and GAL4(DB) fusion plasmids were cotransformed into
PJ69-4 A, as described previously (Clontech manual; James et al, 1996),
and equal aliquots of transformed cells were spread out on plates
containing yeast synthetic complete medium lacking leu and trp (vector
markers) (SC-LT) or leu, trp, his, and ade (vector and interaction
markers) (SC-LTHA). Plates were incubated at 30°C and growth of
colonies was scored after 6 and 10 d. The plating ef®ciencies on -leu,
-trp,-his,-ade plates, compared with the plating ef®ciency on -leu,-trp,
was used as a measure of the strength of the signal generated by the two-
hybrid interaction. Expression of the fusion proteins was analyzed by
immunoblotting with antibodies against the GAL AD or BD (sc-1663
and sc-510, respectively; Santa Cruz Biotechnology, Santa Cruz, CA).
RESULTS
Mapping of b4 mutations on the three-dimensional
structure of the second FNIII (Fig. 1) repeat reveals close
proximity of the amino acids In patients suffering from
nonlethal forms of EB, two missense mutations (R1225H and
R1281W) have been identi®ed in the gene for the integrin b4
subunit. Mapping of the amino acid substitutions caused by these
mutations on the three-dimensional structure of the ®rst pair of b4
FNIII repeats revealed that one (R1281W) is localized in the loop
region that connects two b-strands (EC¢), whereas the other
(R1225H) is present at the N-terminal end of the second FNIII
repeat (Fig 1). Both residues are positioned in close proximity to
each other and together with K1279 may form a binding sequence
of basic residues for a negatively charged protein domain. The basic
residues are clearly separated from the hairpin loop that connects
the b strands C and C¢. This loop, which is composed of the
residues DDN (1262±1264), may constitute another important
binding site, because like the RGD loop in ®bronectin, which
serves as a binding site for integrins, it is well exposed (de Pereda
et al, 1999).
Introduction of R1281W or R1225H mutations in full-length
b4 cDNA prevents the recruitment of plectin into
hemidesmosomes To investigate the role of the above three
positively charged amino acids and that of the negatively charged
DDN loop in the assembly of hemidesmosomes, we generated b4
cDNA constructs containing the mutations R1225H, K1279W,
R1281W, D1263E, or DDDN. First, we veri®ed that the different
b4 mutants were of the correct size by expressing the different
mutant b4 constructs in COS-7 cells, followed by immunoblotting
with antibodies against b4. As shown in Fig 2, all mutant b4
constructs were expressed and the size of the produced polypeptides
corresponded to that of wild-type b4. Subsequently, the constructs
were transfected into PA-JEB cells, a cell line obtained from a
Figure 2. Detection of b4 mutants in lysates of transiently
transfected COS-7 cells. Cells transfected with b4R1225H (lane 1),
b4K1279W (lane 2), b4R1281W (lane 3), b4D1263E (lane 4), b4DDDN (lane 5),
and wild-type b4 (lane 6) were lyzed as described in Materials and
Methods. Protein samples were separated on 6% SDS-PAGE under
nonreducing conditions and analyzed by immunoblotting using MoAb
439-9B.
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patient lacking b4 (Schaapveld et al, 1998), and the distribution of
each mutant was analyzed by immuno¯uorescence microscopy.
PA-JEB cells do not assemble hemidesmosomes, but their
formation is readily induced upon expression of wild-type b4.
Staining with antibodies against b4 or plectin identi®ed these
structures as dots and patches at the cell±substrate contact sites.
Fig 3 shows that all mutant b4 constructs were present at the cell
basis in a pattern that suggests localization in hemidesmosomal
structures. In contrast to wild-type b4, however, which was
colocalized with plectin, in cells expressing the b4 mutants carrying
the R1281W or R1225H mutations, the staining pattern of the
plectin molecule was diffuse, as it was in untransfected PA-JEB cells.
The recruitment of plectin by b4 into hemidesmosomes was not
affected by the mutation K1279W, which occurs in the same loop
as R1281W. Similarly, deletion of the DDN loop or the D1263E
mutation did not abrogate the recruitment of plectin by b4 (Fig 3).
The mutations R1281W or R1225H in b4 abolish the
interaction with plectin in yeast The ®nding that wild-type
b4 and the b4 mutants K1279W, D1263E, and DDDN, but not
b4 (R1281W) and b4 (R1225H), recruited plectin into
hemidesmosome-like structures suggests that the R1281W and
R1225H mutations prevent an interaction between b4 and plectin.
We sought evidence for this using a two-hybrid assay in which a
positive interaction confers adenine and histidine prototrophy, by
allowing the expression of the ADE2 and His genes. GAL4±b4
fusion constructs containing residues 1115±1457 of wild-type b4 or
the various b4 mutants were created. The fusion constructs are
stably expressed in yeast and their levels of expression are similar as
determined by immunoblotting with antibodies against GAL4 (not
shown).
As shown in Fig 4, wild-type b4 (1115±1457) interacts with the
ABD of plectin (1±339), as measured by the growth of yeast on the
selective plates. The mutation K1279W in b4 only slightly reduced
the interaction between b4 (1115±1457) and the ABD of plectin,
whereas deletion of the DDN (1262±1264) amino acids or the
D1263E mutation had no detectable effect. The R1225H or
R1281W mutations completely abolished the interaction with
plectin, consistent with the inability of full-length b4 containing
these mutations to recruit plectin. All constructs showed an
Figure 4. Yeast two-hybrid analysis of a direct interaction between b4 mutants and the ABD of plectin. Cotransformation of yeast host
strain PJ69-4 A with b4 mutants in the pACT2 (AD) vector and plectin ABD or b41457±1752 in the pAS2.1 (BD) vector. Transformation mixtures were
spread on SC-LT and SC-LTHA plates and grown at 30°C. Plating ef®ciency on selective SC-LTHA plates is expressed as a percentage of the plating
ef®ciency on nonselective SC-LT plates from the same transformation. Plates were scored after 5 and 10 d. All ef®ciencies listed represent an average of
multiple independent transformations. ++, plating ef®ciency on SC-LTHA is > 80% of the plating on SC-LT, colonies are fully developed on day
5; +, 40%±80% of the plating on SC-LT, colonies are small on day 5; ±, no colonies on selective plates after 10 d of growth. Note that the interaction
between the b41115±1457 mutants (K1279W, D1263E, and DDDN) and the plectin±ABD fusion protein, but not between b41115±1457 and b41457±1752,
could also be shown by the growth of colonies on selective plates containing 2 mM 3-amino-1,2,4-triazole (a His antagonist).
Figure 3. Immuno¯uorescence analysis of plectin recruitment by b4 mutants. b4-de®cient PA-JEB keratinocytes were transfected with cDNA
encoding wild-type b4 and various b4 mutants. Cells were ®xed, double-immunolabeled, and processed for immuno¯uorescence microscopy using
mouse MoAb 121 against HD1 and rat MoAb 439-9B against b4. Composite images were generated by superimposition of the green (HD1/plectin)
and red (b4) signals with areas of overlap appearing as yellow. Micrographs with both transfected and untransfected cells are shown. In cells expressing
wild-type b4 or the b4 mutants, b4K1279W, b4D1263E or b4dDDN, but not b4R1281W or b4R1225H, HD1/plectin is colocalized with b4 in
hemidesmosome-like structures.
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interaction with a fragment containing the C-tail of b4 (1457±
1752), an interaction that we previously have shown to involve the
region 1382±1436 of the connecting segment (Nievers et al, 1999).
DISCUSSION
Using cell transfection experiments in combination with yeast two-
hybrid assays, we demonstrated that the introduction of either of
two separate point mutations in the second FNIII repeats of the
integrin b4 subunit abrogates binding of the ABD of plectin to b4.
These results help to explain why these mutations found in patients
with nonlethal forms of EB result in a mild blistering phenotype.
Because of an inability of b4 to recruit plectin into hemidesmo-
somes, the linkage of the intermediate ®laments to hemidesmo-
somes is likely to be compromised, causing fragility of the cells and
rupturing of the cell upon application of stress. Similar phenotypes
are described in null mutant mice for the plectin gene, in which
hemidesmosomes appeared to be unaffected although their mech-
anical stability was reduced (AndraÈ et al, 1997).
The data further indicate that an important binding site for
plectin is located in the second FNIII repeat of b4 and that
mutations in this part of the molecule may lead to loss of
recruitment of plectin by b4. Although our results are in perfect
agreement with ®ndings published previously (Niessen et al, 1997a;
Geerts et al, 1999), they are in apparent contrast to ®ndings
reported by Rezniczek et al (1998), who showed the presence of a
major binding site for b4 in plectin in the region C-terminal of the
ABD, using in vitro binding assays. In addition, these authors
presented evidence that there are two binding sites on b4 for
plectin, one in the connecting segment and another in the extreme
C-terminal part following the second pair of FNIII repeats of b4.
We recently could con®rm the presence of these binding sites in
two-hybrid assays (Koster et al, manuscript in preparation). The
importance of these sites for the recruitment of plectin by b4 is
uncertain, however, because, despite the fact that these binding
sites are intact in the b4 constructs carrying the R1225H or the
R1281W mutation, these b4 mutants were unable to recruit plectin
into hemidesmosomes. Nevertheless, it is possible that once plectin
is recruited by binding of b4 to the plectin ABD, these additional
plectin binding sites in the connecting segment and the extreme C-
tail of b4 may help to strengthen the interaction between these two
molecules. The importance of the binding site for plectin in the
second FNIII repeat explains the phenotypes in the patients with
nonlethal forms of EB (Pulkkinen et al, 1998; Nakano et al, 2001).
Interestingly, the mutation K1279W, which occurs in the same
loop structure as R1281W, only slightly affected the interaction
between plectin and b4. Because, like K1279, R1281 is expressed
on the surface of the second FNIII repeat of b4, it is unlikely that
an R1281W mutation abolishes the interaction with plectin by
inducing a destabilization of the repeat. Rather it suggests that the
R1281 residue, and perhaps also R1225, directly take part in
interaction with plectin, possibly by forming a salt bridge with a
negatively charged amino acid in the ABD of plectin. Currently,
we are testing the effects of different amino acid substitutions in the
ABD of plectin on the binding of this domain to b4.
Although the DDN sequence in the second FNIII repeat of the
b4 molecule could well have been a binding site for plectin, we
showed in both cell transfection experiments and yeast two-hybrid
assays that this sequence is not involved in the binding to the ABD
of plectin. This does not rule out, however, that this sequence
could bind to another region of the plectin molecule, or even to
another protein.
In conclusion, we have mapped two mutations (R1225H and
R1281W), identi®ed in patients with nonlethal EB, on the three-
dimensional structure of the second FNIII repeat of b4 and have
shown that these mutations are located close to each other.
Mutation of these residues in a full-length b4 cDNA construct leads
to an inability of the protein to recruit plectin, whereas three other
mutations had no effect. Studies in yeast indicate that R1225 and
R1281 are essential for binding plectin. We endeavor to clarify the
exact site of interaction on the ABD of plectin in another study to
fully understand the mechanism of this interaction.
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